Lung Diseases  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00356122: Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Completed
2
53
US
Docetaxel, Oxaliplatin, Bevacizumab
Sanofi, Genentech, Inc.
Non-Small Cell Lung Cancer
08/10
08/10
BELOXAN, NCT01243775: BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

Completed
2
33
RoW
Belotaxel, Docetaxel, Belloxa, Oxaliplatin
Chonnam National University Hospital, Chong Kun Dang Pharmaceutical
Non-Small Cell Lung Cancer
01/13
01/13

Download Options